In 2022, Dr. Özgür Genç together with Professor Peter Scheiffele from the Biozentrum, University of Basel, founded the startup Translation-X with the goal of developing novel therapeutics for autism spectrum disorders. They have now received 150’000 Swiss Francs investment from the Venture Kick initiative.
Researchers at the University of Basel have made significant progress in understanding a rare but serious immune disease. The team has uncovered critical mechanisms involved in the cellular recycling process, thus providing novel therapeutic approaches.
What factors lead to chronic respiratory disease? Researchers investigated this question using health data from about 780 infants. Their analysis shows that children's risk of developing asthma later in life can be more reliably predicted by observing the dynamic development of symptoms during the first year of life.
Until a few years ago, the butterfly known as the southern small white could barely be found north of the Alps. That was before a Europe-wide invasion that brought a huge increase in the insect’s distribution – at the same time as a rapid decrease in genetic diversity within the species.
Caspar Bauhin was probably the most famous botanist of his time. The Basel-based professor collected plants from all over the world and set new standards in botany that continue to have an impact today. Now, he is the subject of an exhibition by the Department of Environmental Sciences, the University Library Basel and the Basel Botanical Society.
Starting next Monday, the fall semester of 2024 will commence at the University of Basel with 12,764 students and doctoral candidates. The number of first-year students and enrolments at Master's level have increased compared to last year. The total number of students is expected to rise above 13,000 again in 2024.
The Swiss National Science Foundation is awarding two SNSF Consolidator Grants to researchers at the University of Basel. The five-year projects in the fields of history and computer science will each receive around CHF 1.7 million in funding.
The Swiss federal government is launching a national initiative to consolidate Switzerland’s leading position in quantum science. This initiative will also benefit the internationally recognized quantum research at the University of Basel: two projects have been approved.
Prof. Dr. Michael N. Hall from the Biozentrum of the University of Basel has been awarded the 2024 Balzan Prize for Biological Mechanisms of Ageing. The cell biologist discovered the protein TOR (target of rapamycin), a key regulator of cell growth and metabolism, which has also been implicated in development, ageing and a wide variety of diseases such as cancer and diabetes.
